Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2557328rdf:typepubmed:Citationlld:pubmed
pubmed-article:2557328lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:2557328lifeskim:mentionsumls-concept:C0039259lld:lifeskim
pubmed-article:2557328lifeskim:mentionsumls-concept:C0061688lld:lifeskim
pubmed-article:2557328lifeskim:mentionsumls-concept:C0242210lld:lifeskim
pubmed-article:2557328lifeskim:mentionsumls-concept:C1149539lld:lifeskim
pubmed-article:2557328pubmed:issue36lld:pubmed
pubmed-article:2557328pubmed:dateCreated1990-2-1lld:pubmed
pubmed-article:2557328pubmed:abstractTextMembrane-associated and soluble forms of folate binding protein (FBP) have been identified in mammalian tissues and biological fluids. Despite their solubility differences, these two forms are functionally similar, immunologically cross-reacting, and have the same apparent molecular weights. In this study we demonstrate, for the first time, that the membrane FBP of cultured human KB cells contains a glycosyl-phosphatidylinositol (GPI) tail which is responsible for its hydrophobic properties and distinguishes it from the soluble FBP released into the medium. Treatment of the purified membrane FBP with phospholipase C specific for phosphatidylinositol (PI-PLC) removed the GPI tail and converted it to the soluble form without a change in apparent Mr by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. In addition, virtually all of the folate binding sites on the plasma membrane of the intact cells were released as soluble, functional FBP following treatment with PI-PLC. The GPI tail contained 1-O-alkyl-2-O-acylglycerol as a mixture of fatty alcohols in ether linkage at C1 of the glycerol backbone and almost exclusively docosanoic acid (22:0) as the fatty acid on C2. The inositol also contained a mixture of fatty acids (16:0, 18:0, 18:1, 20:4, 22:0) located on a site other than the C2 position since the FBP was susceptible to PI-PLC cleavage. After nitrous acid deamination, the aqueous portion of the FBP contained covalently bound fatty acids, predominantly palmitate (16:0) and stearate (18:0), indicating the presence of additional acyl groups attached to the peptide in the form of amide, ester, or thioester linkage.lld:pubmed
pubmed-article:2557328pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2557328pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2557328pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2557328pubmed:languageenglld:pubmed
pubmed-article:2557328pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2557328pubmed:citationSubsetIMlld:pubmed
pubmed-article:2557328pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2557328pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2557328pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2557328pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2557328pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2557328pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2557328pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2557328pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2557328pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2557328pubmed:statusMEDLINElld:pubmed
pubmed-article:2557328pubmed:monthDeclld:pubmed
pubmed-article:2557328pubmed:issn0021-9258lld:pubmed
pubmed-article:2557328pubmed:authorpubmed-author:SlomianyB LBLlld:pubmed
pubmed-article:2557328pubmed:authorpubmed-author:LuhrsC ACAlld:pubmed
pubmed-article:2557328pubmed:issnTypePrintlld:pubmed
pubmed-article:2557328pubmed:day25lld:pubmed
pubmed-article:2557328pubmed:volume264lld:pubmed
pubmed-article:2557328pubmed:ownerNLMlld:pubmed
pubmed-article:2557328pubmed:authorsCompleteYlld:pubmed
pubmed-article:2557328pubmed:pagination21446-9lld:pubmed
pubmed-article:2557328pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:2557328pubmed:meshHeadingpubmed-meshheading:2557328-...lld:pubmed
pubmed-article:2557328pubmed:meshHeadingpubmed-meshheading:2557328-...lld:pubmed
pubmed-article:2557328pubmed:meshHeadingpubmed-meshheading:2557328-...lld:pubmed
pubmed-article:2557328pubmed:meshHeadingpubmed-meshheading:2557328-...lld:pubmed
pubmed-article:2557328pubmed:meshHeadingpubmed-meshheading:2557328-...lld:pubmed
pubmed-article:2557328pubmed:meshHeadingpubmed-meshheading:2557328-...lld:pubmed
pubmed-article:2557328pubmed:meshHeadingpubmed-meshheading:2557328-...lld:pubmed
pubmed-article:2557328pubmed:meshHeadingpubmed-meshheading:2557328-...lld:pubmed
pubmed-article:2557328pubmed:meshHeadingpubmed-meshheading:2557328-...lld:pubmed
pubmed-article:2557328pubmed:meshHeadingpubmed-meshheading:2557328-...lld:pubmed
pubmed-article:2557328pubmed:meshHeadingpubmed-meshheading:2557328-...lld:pubmed
pubmed-article:2557328pubmed:meshHeadingpubmed-meshheading:2557328-...lld:pubmed
pubmed-article:2557328pubmed:year1989lld:pubmed
pubmed-article:2557328pubmed:articleTitleA human membrane-associated folate binding protein is anchored by a glycosyl-phosphatidylinositol tail.lld:pubmed
pubmed-article:2557328pubmed:affiliationDepartment of Medicine, State University of New York-Health Science Center, Brooklyn.lld:pubmed
pubmed-article:2557328pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2557328pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:2557328pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2557328lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2557328lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2557328lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2557328lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2557328lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2557328lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2557328lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2557328lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2557328lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2557328lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2557328lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2557328lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2557328lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2557328lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2557328lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2557328lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2557328lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2557328lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2557328lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2557328lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2557328lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2557328lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2557328lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2557328lld:pubmed